Podcasts about cancer survivorship

Cancer Survivorship (6-5-25)

Samira, a breast cancer survivor and CEO of Manta Cares, discusses the latest advancements in cancer treatment with Dr. Doug Blayney at the ASCO conference. They explore the significant impact of exercise on cancer treatment tolerance and survival, the de-escalation of chemotherapy, the introduction of new therapies like SERDs and antibody drug conjugates, and the role of circulating tumor DNA in monitoring cancer recurrence. The conversation emphasizes the importance of patient convenience and self-advocacy in cancer care.About Our Guest:Douglas W. Blayney, MD is a Professor of Medicine (Oncology), Emeritus, former Medical Director of Stanford Cancer Center, and specializes in the treatment of breast cancer. He has a special interest in the quality and value of cancer care. Dr. Blayney is a past president of the American Society of Clinical Oncology (ASCO), a founder of the ASCO Quality Symposium, a co-author of the ASCO value framework descriptions, and instigated the ASCO clinical "big data" effort, which is now CancerLinQ. He received the inaugural Ellen Stovall Award for Leadership in Patient Centered Care from the National Coalition for Cancer Survivorship in 2016. He was previously a Professor of Internal Medicine and Medical Director of the Comprehensive Cancer Center at the University of Michigan, and prior to that practiced and led Wilshire Oncology Medical Group, Inc. a physician owned multidisciplinary oncology practice in southern California. He has expertise on clinical trial development, use of oncology drugs in clinical practice, reimbursement and marketing strategies and information technology use.Chapter Codes00:00 The Impact of Exercise on Cancer Treatment02:00 Interview at ASCO Starts06:00 Advancements in Cancer Treatment: De-escalation and AI11:52 Emerging Therapies: SERDs and Antibody Drug Conjugates18:11 Circulating Tumor DNA: A New Frontier in Monitoring24:01 Convenience in Cancer Care: A Patient-Centric ApproachTakeaways- Regular exercise can increase tolerance to cancer treatments.- Data shows exercise has tangible benefits on survival rates.- De-escalation of chemotherapy is a key focus in cancer treatment.- AI is being integrated into cancer treatment guidelines.- Patients can take proactive steps to improve their health.- Oral SIRDs are emerging as a more convenient treatment option.- Antibody drug conjugates target cancer cells with fewer side effects.- Circulating tumor DNA can help detect cancer recurrence earlier.- Convenience in treatment is becoming a priority for patients.- Competition among treatments may help reduce costs for patients.Tags & Keywords:cancer treatment, ASCO, exercise, AI, SIRDs, antibody drug conjugates, circulating tumor DNA, patient care, chemotherapy, cancer survival, health technologyConnect with Us:Enjoyed this episode? Make sure to subscribe, rate, and review! Follow us on Instagram, Facebook, or Linkedin @mantacares and visit our website at mantacares.com for more episodes and updates.Listen Elsewhere: Website: https://mantacares.com/pages/podcast?srsltid=AfmBOopEP5GJ-Wd2nL-HYAInrwerIVhyJw67salKT-r9Qb_gadBvbHie YouTube: https://youtu.be/UjsAtpbedA8 Spotify: https://open.spotify.com/episode/7HwhjXHZU0ZWWVkXrCSV7V?si=d5e986f0885a4bbb Apple: https://podcasts.apple.com/us/podcast/cervical-cancer-and-hpv-what-you-need-to-know/id1622669098?i=1000710235401 Disclaimer:All content and information provided in connection with Manta Cares is solely intended for informational and educational purposes only. This content and information is not intended to be a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

Besties with Breasties: Alcohol, Cancer Survivorship, and Healthy Lifestyles In this episode of the Besties with Breasties podcast, hosts Sarah Hall, a certified health and wellness coach, and Beth Wilmes, founder of the nonprofit Faith Through Fire, discuss their personal experiences with alcohol consumption post-breast cancer diagnosis. They delve into the rise of alcohol dependence among middle-aged individuals, particularly cancer survivors, and its negative impacts on mental and physical health. The podcast emphasizes understanding why people drink, the risks associated with alcohol for cancer survivors, and offers practical guidance on reducing alcohol intake. Highlights include insightful discussions on mental health, societal influences like 'mom wine culture,' and healthier coping mechanisms. The episode also features a humorous segment called 'Boobs in the News' and sponsorship messages promoting resources for breast cancer survivors. 00:00 Introduction to the Besties with Breasty Podcast 01:06 Discussing Alcohol and Lifestyle Changes 02:51 Impact of Alcohol on Cancer Survivors 03:15 Faith Through Fire Survivorship Bootcamp 09:55 Alcohol's Effect on Mental Health 12:23 Boobs in the News: Funny and Ridiculous Stories 15:13 The Origins of Pokemon 15:32 Pokemon Go Phenomenon 15:52 The Myth of Overnight Success 16:20 Auctioneer's Ingenuity 16:39 Personal Reflections on Alcohol 18:02 Mom Wine Culture 18:44 Awareness and Coping Mechanisms 20:26 Social Dynamics and Alcohol 26:11 Alternatives to Alcohol 28:10 Final Thoughts and Sponsor Message

In this episode of Bench to Bedside, Dr. Roy Jensen, vice chancellor and director of The University of Kansas Cancer Center, is joined by two special guests: Paul Seyferth, a stage IV lung and prostate cancer survivor and creator of the Wall of Hope Project at KU Cancer Center, and Rebecca Keunen, clinical case manager lead at the cancer center and a cancer survivor herself. They discuss Paul's emotional journey through his diagnosis and the creation of the Wall of Hope installation, which features cancer patients' photos, videos and stories to inspire hope. Rebecca shares her involvement in the project and her perspective on the importance of personal connections in cancer care. Both guests offer valuable insights and advice for cancer patients and survivors, emphasizing the importance of strategic thinking and support systems in the survival journey. Do you have questions about cancer? Call our Bench to Bedside Hotline at (913) 588-3880 or email us at benchtobedside@kumc.edu, and your comment or question may be shared on an upcoming episode! If you appreciated this episode, please share, rate, subscribe and leave a review. To ensure you get our latest updates, For the latest updates, follow us on the social media channel of your choice by searching for KU Cancer Center. Links from this Episode: Learn more about the Wall of Hope and view videos from participants Learn more about survivorship care at KU Cancer Center Find information about Paul's book, “Will to Live:  A Deep Survival Guide to stage IV Lung Cancer” Learn more about the Brandmeyer Patient Resource Center at KU Cancer Center

Learn the terms healthcare teams use after cancer treatment is complete, and why they hesitate to use the word "cured."  https://bit.ly/3FfnfUxAdvances in cancer diagnosis, screening, and treatment have greatly improved the 5-year survival rates of most people with cancer over the last 30 years. Long-term survivors of cancer are more and more common, and research is increasingly directed at helping people live well after a diagnosis of cancer. But even so, many oncologists still hesitate to use the word “cure” with their patients. We talk with Dr. Jeanne Ford about the difference between the terms No Evidence of Disease (NED), remission, cure, and cancer free.In this Episode: 03:11 | Travel-Vermont and Vermont Chicken Pot Pie04:25 | The Trouble with Using the Phrase "Cancer Free"10:20 | Why We Don't Say Cancer is Cured12:00 | How Dr Ford Explains NED to Her Patients19:17 | What Does "Cure" Really Mean?29:38  | How Do Native Communities Treat the Concept of a Cancer Cure32:51 | The Role of Hope and How to Deliver Honest Information37:28 | Addressing Fear of Recurrence and Uncertainty about Future44:13 | Cancer Survivorship and Surveillance46:03 | Outro#survivor #cancersurvivor #cancerfree #remisssion #NED #cancercured #treatmentfinished #survivorship #oncologynurse #caregiver #palliativecare #everyonedies #everydayisagift #cancerjourneySupport the showGet show notes and resources at our website: every1dies.org. Facebook | Instagram | YouTube | mail@every1dies.org

Send us a textWelcome to the latest Series of Supportive Care Matters, a podcast hosted by Medical Oncologist and International Cancer Survivorship Expert, Professor Bogda Koczwara AM.The landscape of cancer survivorship is evolving before our eyes. As treatment advances allow people with metastatic cancer to live longer, we're witnessing the emergence of a population that exists in what medical oncologist Dr Lori Spoozak calls "the place in between" – not curable but not actively dying.In this eye-opening conversation, researchers Associate Professor Nick Hart and Dr. Andrea Smith (who herself lives with metastatic breast cancer) explore the unique challenges faced by those living with advanced cancer. While survivorship programs have traditionally focused on post-treatment care, metastatic patients are typically on treatment for life, navigating constant healthcare interactions, accumulating side effects and facing the certainty rather than just the fear of disease progression.The discussion reveals how metastatic cancer patients have often fallen through the cracks – excluded from survivorship programs yet not appropriately served by palliative care services that focus primarily on end-of-life needs. This growing population faces what Dr. Smith describes as supportive care needs "on steroids" – intensified physical, psychological, financial and practical challenges that require specialised approaches.Hart and Smith share their ground-breaking work developing the first international standards for metastatic cancer survivorship care, now translated into 14 languages to guide implementation worldwide. They emphasise that improving care requires action on multiple fronts: better education for healthcare professionals, redesigned care models, dedicated peer support programs and recognition that survivorship care is everyone's responsibility rather than the domain of any single provider.Whether you're a healthcare professional, researcher, patient advocate or someone living with cancer, this conversation challenges conventional thinking about survivorship and offers a compelling vision for more inclusive, responsive care. Discover why supporting those living for years with incurable cancer represents both an urgent challenge and a tremendous opportunity to enhance quality of life for this overlooked population.Visit www.oncologynews.com.au for show notes and more information about Supportive Care Matters.This conversation is proudly produced by the Podcast Team at The Oncology Podcast, part of the Oncology Media Group Australia.

    Nayana Ferguson shares her experience facing both pancreatic cancer and breast cancer and rewriting her Next Chapter. After earning a successful corporate career and recovering from her health challenges, Nayana and her husband, Don, followed a dream. They launched Anteel Tequila in 2018 and have been racking up awards ever since. Nayana joins a small but growing of fearless black women launching successful spirits brands.Fearless Fabulous You is broadcast live Wednesdays at 12 Noon ET on W4WN Radio - Women 4 Women Network (www.w4wn.com) part of Talk 4 Radio (www.talk4radio.com) on the Talk 4 Media Network (www.talk4media.com).Fearless Fabulous You Podcast is also available on Talk 4 Media (www.talk4media.com), Talk 4 Podcasting (www.talk4podcasting.com), iHeartRadio, Amazon Music, Pandora, Spotify, Audible, and over 100 other podcast outlets.

What does it mean to survive a diagnosis, and live with cancer? For this episode, we return to the subject that launched the very first season of Overlooked: ovarian cancer, with Teresa Arthur - aka Golda's Mom. Teresa was diagnosed in 2018 and has been living with recurring ovarian cancer for the last seven years, spending almost half of every year in chemotherapy treatment. She talks candidly with Golda about her health challenges and quality of life in survivorship. Take a listen to Teresa's story with ovarian cancer, which we told in our very first season here: https://overlooked.simplecast.com/episodes/fluid-puppySubscribe to the newsletter for more background on this episode: https://overlookedpodcast.kit.com/e4b85028b6If you're in New York City, come to our first listener ‘Meet & Greet' at 787 Coffee in Manhattan on May 31st. Tickets are free but limited - register here.  https://www.eventbrite.ca/e/overlooked-podcast-meet-greet-tickets-1352683656229?aff=oddtdtcreator LIKE WHAT YOU HEAR? Support the show by:- Leaving a review on Apple, Spotify, or wherever you're listening.- Becoming a Patron - Overlooked is on Patreon, where you can and get rewards like merch, the ability to send in questions for expert guests, and a 'backstage pass' to the show. New to Overlooked? Welcome. Overlooked was launched in 2023 to tell the story of ovarian cancer through one woman's story. In 2024 the show started to cover other overlooked topics in women's health - and there are many. The show is hosted by Golda Arthur, an audio journalist and producer. EMAIL US: hello@overlookedpod.com FOLLOW US:Instagram https://www.instagram.com/overlookedpod/LinkedIn https://www.linkedin.com/company/105541285/admin/dashboard/ LEARN MORE: https://overlookedpod.com/ DISCLAIMER What you hear and read on ‘Overlooked' is for general information purposes only and represents the opinions of the host and guests. The content on the podcast and website should not be taken as medical advice. Every person's body is unique, so please consult your healthcare professional for any medical questions that may arise.

In this episode of The Patient From Hell, host Samira Daswani speaks with Dr. Sara Char about her journey into oncology, the evolution of cancer biology, and the significant role of the microbiome in colon cancer. They discuss the complexities of cancer survivorship, the effectiveness of different methods of delivering survivorship care plans, and the importance of colonoscopy in monitoring colorectal cancer. The conversation also delves into the impact of diet on cancer risk, emphasizing the need for a comprehensive understanding of dietary patterns rather than focusing solely on individual foods. In this conversation, Dr. Sara Char discusses various aspects of survivorship care for colorectal cancer patients, focusing on dietary recommendations, exercise, and the emotional challenges faced during the transition from active treatment to survivorship. The dialogue emphasizes the importance of balancing nutrition, understanding the role of GLP-1 agonists, and the need for a supportive care team. Additionally, the conversation highlights the unique mental health needs of survivors and the significance of providing patients with a roadmap for their cancer journey.About Our Guest:Dr. Sara Char is a hematology and oncology fellow at Dana-Farber Cancer Institute. She specializes in the care of patients with gastrointestinal cancers with a specific interest in young-onset colorectal cancer. Her research explores the molecular underpinnings of diet and lifestyle factors implicated in colorectal cancer development and progression. Dr. Char received her M.D. from Tufts University School of Medicine and completed her residency training in internal medicine at Massachusetts General Hospital, where she also served as chief resident. Outside of work, she is a self-identified foodie and devoted dog-mom. Resources & Links:This episode was supported by the Patient Centered Outcomes Research Institute (PCORI) and features the PCORI research study here: https://pubmed.ncbi.nlm.nih.gov/34302474/ - ‘Simplifying Survivorship Care Planning: A Randomized Controlled Trial Comparing 3 Care Plan Delivery Approaches'Chapter Codes00:00 Exploring the Microbiome and Colon Cancer05:59 The Transition to Survivorship Care11:57 Understanding Adherence in Survivorship Plans17:49 The Role of Colonoscopy in Survivorship24:06 Dietary Patterns and Cancer Risk25:04 Inflammatory Diet and Health Outcomes28:11 Dietary Recommendations for Cancer Survivors30:34 Exercise and Body Composition in Cancer Care31:59 Managing GI Issues with GLP-1 Agonists34:43 Navigating Multidisciplinary Care35:50 The Transition from Active Treatment to Survivorship38:08 Mental Health Challenges Post-Treatment41:41 The Need for Psycho-Oncology Support46:47 The Importance of Patient Education and ResourcesConnect with Us:Enjoyed this episode? Make sure to subscribe, rate, and review! Follow us on Instagram, Facebook, or Linkedin @mantacares and visit our website at mantacares.com for more episodes and updates.Disclaimer:All content and information provided in connection with Manta Cares is solely intended for informational and educational purposes only. This content and information is not intended to be a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.This episode was supported by an award from the Patient-Centered Outcomes Research Institute.

There's no shortage of conflicting nutrition advice for hormone-positive breast cancer survivors—one day a food is a "miracle cure," the next, it's labeled a "cancer trigger." In this episode, I break down three common myths and misconceptions about food and breast cancer survivorship. You'll learn what's actually backed by science, what's fear-based misinformation, and how to find a balanced, stress-free approach to nourishing your body after hormone-positive breast cancer._________________________________________Click here to apply to my Peaceful Plate program! Get my FREE guide The Five Foods Survivors Should Eat; click here!Follow me on Instagram @hormone.breastcancer.dietitian

Our survivorship topic speaker today is Dara Kurtz. Dara is a breast cancer survivor, author of Crush Cancer, and survivorship mentor. As of March 2025, she is also Cancer Services' Survivor Engagement Coordinator! Listen to our interview with Dara to hear: - The most significant mental or emotional shift she experienced after finishing treatment - How she began to rebuild identity after cancer - What tools or habits have helped her the most in navigating life post-cancer - The role that community played in her healing

In this episode of the Bench to Bedside podcast Dr. Roy Jensen, vice chancellor and director of The University of Kansas Cancer Center, discusses the critical topic of alcohol consumption and its link to cancer risk with Dr. Lauren Nye, medical oncologist at the cancer center and associate professor of Internal Medicine at the University of Kansas Medical Center. They delve into the recent advisory from the US Surgeon General highlighting the increased cancer risk associated with alcohol consumption, explore how alcohol can promote cancer development through various mechanisms, and offer practical advice for reducing alcohol intake. Dr. Nye underscores the importance of public awareness and the role of healthcare professionals in disseminating this information, while also emphasizing the need for sustainable lifestyle changes. Do you have questions about cancer? Call our Bench to Bedside Hotline at (913) 588-3880 or email us at benchtobedside@kumc.edu, and your comment or question may be shared on an upcoming episode! If you appreciated this episode, please share, rate, subscribe and leave a review. To ensure you get our latest updates, For the latest updates, follow us on the social media channel of your choice by searching for KU Cancer Center. Links from this Episode: Read the US Surgeon General's Advisory “Alcohol and Cancer Risk” Read “Understanding Breast Cancer Prevention” by Dr. Lauren Nye on the KU Cancer Center blog Learn about cancer prevention and risk reduction on the KU Cancer Center website

In this episode, I sit down with Rebecca Walker, a coach and podcast host, but also my very dear friend who has helped me personally so much over the years. We talk about the power of friendship and support when navigating cancer and mental health challenges. We explore the emotional ups and downs of survivorship, the impact of anxiety and the role of friends.Takeaways from our conversation:Friendship can be a lifeline during tough times.How coaching can helpRedefining success after cancer to embracing vulnerabilityWhat it really means to be a supportive friend.Cancer affects mental health just as much as physical health.Sharing our stories helps us feel less alone.What's wrong with ‘assumptions'This conversation is filled with wisdom, honesty, and hope. I can't wait for you to listen!Episode Highlights:00:00 Intro05:26 Embracing Vulnerability and Openness08:35 "Prioritise Big Rocks First"14:42 Coaching Conversations: Navigating Health Decisions16:46 Supportive Friendships: Guidance Without Directing20:12 "Podcast Insights on Assumptions"31:14 "Reflections on Cancer and Recovery"33:40 Be the Friend You SeekListen to Rebecca's podcast here https://headflex.co.uk/#83b77e94-775f-4144-ab1b-c69a481a6128 Connect with us:For more information and resources visit our website: www.menopauseandcancer.org Or follow us on Instagram @menopause_and_cancerJoin our Facebook group: www.facebook.com/groups/menopauseandcancerchathub

In this inspiring episode, I sit down with Rachel Frankenthal, a board-certified Physician Assistant and Menopause Society Certified Practitioner, whose work is transforming the lives of cancer survivors. Rachel specialises in gynaecological oncology at UCLA, supporting women through both cancer treatment and survivorship—particularly those navigating treatment-induced menopause.But Rachel's story is anything but ordinary! From her early days as a Broadway performer to becoming a leading voice in survivorship care, she shares how her journey shaped her passion for holistic, patient-centred healthcare. She has played a pivotal role in developing UCLA's Gynaecologic Cancer Survivorship Program and started a dedicated menopause clinic to support survivors in reclaiming their well-being.Join us as we discuss the power of integrative care, movement, and mindfulness, and how Rachel is changing the future of menopause support for cancer survivors. This conversation is full of wisdom, hope, and a reminder that the right care can change lives.Episode Highlights:00:00 Intro05:27 Rachel's Yoga Journey13:07 Comprehensive Patient Follow-Up Visits16:51 Post-Treatment Confusion and Anxiety20:15 Embracing a Healthcare Paradigm Shift23:13 Menopausal Symptoms in Cancer Survivors24:30 "Advocating Awareness in Cancer Care"29:09 Empowering Mid-Level Providers in Oncology31:42 Yoga Program Reduces Treatment Side Effects35:35 Community Healing Through Connection38:17 Normalising Post-Cancer Intimacy ChallengesFind Rachel here https://www.instagram.com/rachelfrankenthal/ Attached are resources: The British Gyn Cancer Society Guidelines https://thebms.org.uk/publications/bms-guidelines/management-of-menopausal-symptoms-following-treatment-of-gynaecological-cancer/- Here's the link to Rachel's course "Hormone Therapy for Gyn Cancer Survivors": https://heatherhirschacademy.com/course/managing-hormone-therapy-for-gynecologic-cancer-survivors/Connect with us:For more information and resources visit our website: www.menopauseandcancer.org Or follow us on Instagram @menopause_and_cancerJoin our Facebook group: www.facebook.com/groups/menopauseandcancerchathub

Episode Summary:In this episode of The Patient from Hell, we sit down with Samira and Dr. Samantha, two storytellers who delve into the power of personal narratives, cultural identity, and representation. They share their experiences navigating different spaces, finding their voices, and embracing authenticity. Whether you're interested in storytelling, personal growth, or the intersections of culture and identity, this episode offers deep insights and inspiration.About Our Guest:Dr. Samantha Siegel is an onco-pcp and survivorship physician at Kaiser Permanente. She has survived relapsed/refractory Hodgkin Lymphoma, including an autologous bone marrow transplant in June 2022. This has made her passionate about integrative oncology, AYA survivorship, longterm toxicities, returning to work after cancer and more. Dr. Siegel is the cofounder of PCP-ONC CARES program, a longitudinal cancer survivorship care model beginning at diagnosis and she serves as the current director of Cancer Survivorship for Kaiser San Francisco. She is the host of AIM at Melanoma's supportive cancer care podcast, “Beyond the Clinic.” Dr. Siegel is focused on elevating cancer survivorship to a distinct board certification status. She lives in Davis with her husband, three kids and energetic dog. They enjoy outdoor activities and plant-based living.Key Highlights:[00:10:30] The Power of Storytelling in Identity: Sam and Samira discuss how personal experiences shape the stories we tell and the impact storytelling has on self-identity and cultural understanding.[00:22:45] Challenges in Representation: They share their experiences with representation in the media and the barriers they've faced in telling authentic stories.[00:35:00] Embracing Authenticity in Creative Work: A conversation about the importance of staying true to oneself and how authenticity can lead to more meaningful storytelling and connection.Key Moments:[00:02:15] - Introduction to Sam and Samira[00:10:30] - How personal experiences shape storytelling[00:22:45] - Overcoming challenges in representation[00:35:00] - The impact of authenticity in creative work[00:48:20] - Closing thoughts and takeawaysConnect with Us: Enjoyed this episode? Make sure to subscribe, rate, and review! Follow us on Instagram, Facebook, or Linkedin @mantacares and visit our website at mantacares.com for more episodes and updates.Resources & Links:This episode was supported by the Patient Centered Outcomes Research Institute (PCORI) and features the PCORI ⁠study⁠ “Effects of a Communication Intervention Randomized Controlled Trial to Enable Goals-of-Care Discussions” by Nina BickellDisclaimer:All content and information provided in connection with Manta Cares is solely intended for informational and educational purposes only. This content and information is not intended to be a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.This episode was supported by an award from the Patient-Centered Outcomes Research Institute.

Lidia Schapira, MD, is a Professor of Medicine at Stanford Comprehensive Cancer Institute and Director of Stanford's Cancer Survivorship program. A nationally renowned expert in breast cancer, Dr. Schapira has pioneered workshops and helped develop innovative educational programs to improve the communication skills of cancer clinicians by building experienced and compassionate teams. She has been a champion of promoting patient activation and self-management at all phases of the cancer journey. She is the former Editor-in-Chief of cancer.net, and consultant editor for the Journal of Clinical Oncology. She also hosts JCO's Cancer Stories: The Art of Oncology podcast which features stories, dialogue, and personal reflections that explore the experience of living with cancer or caring for people with cancer.  “We need to redefine what we mean by failure and success. Failure is not that the patient dies. Failure is that the patient dies abandoned, alone, or in pain. One can still die of an incurable illness, but that doesn't necessarily mean that we as the treating physicians have failed. If we can figure out how to treat an illness and support a person in a family, this is the best combination.” In this episode of The Medicine Mentors, Dr. Lidia Schapira offers an innovative perspective on success, teaches us how to find strength in the bleakest moments, and mentors us on how to outgrow conventional definitions of failure. Pearls of Wisdom:   1. The most important thing to look for within is what it is that tickles us, inspires us. Then trying to preserve at least some of our time to work on that to keep us engaged.  2. The Art of Oncology is finding the human side of the patients we care for.   3. I do this meditative hand-washing before I enter a room so I can be fully present and let them know I'm interested in them, not just the disease.  4. Have an open mind and be very curious, pursue answers in places that aren't obvious. 5. I've learned over the years to sit with emotion and not be eager to fix or stop it. Support people by letting them express their emotions.  

In this heartfelt episode of Real Chicks Rock!® Presents Real Discussions, host Michelle Dawes Birt welcomes Angel Thompson, a brave breast cancer survivor and advocate. Together, they delve into Angel's inspiring journey of resilience, diagnosis, and empowerment as she navigates life beyond her breast cancer diagnosis. Angel shares her story of being diagnosed at the young age of 30, the challenges she faced in advocating for her health, and the importance of self-advocacy in the medical community. From her experiences with chemotherapy and radiation to her ongoing treatment in a clinical trial, Angel emphasizes the significance of awareness and early detection, especially for young women. Special thanks to my guest, Angel Thompson, for sharing her powerful story and insights. Are you subscribed to the podcast? If not, make sure to subscribe so you never miss an episode. Please remember to rate, comment, share, and download your favorite episodes.  Connect with Real Chicks Rock!  Instagram - https://www.instagram.com/realchicksrock  Facebook - https://www.facebook.com/RealChicksRock1  Twitter - https://twitter.com/RealChicksRock1  Website: www.RealChicksRock.com  Connect with Angel Thompson:  Instagram: https://www.instagram.com/angelaftercancer #RealChicksRock #RealDiscussions #BreastCancer #AngelThompson #Survivor #Advocacy #HealthAwareness #Empowerment #Inspiration #CommunitySupport #WomenSupportingWomen #Podcast

In this episode of Game Over: c*ncer, hosts Dana Nichols and Val Solomon dive into the complex and emotional tightrope of balancing hope and reality in pediatric cancer.  Joining the conversation is Dr. Claire Wakefield, a psychologist, researcher, and professor specializing in pediatric psycho-oncology. Dr. Wakefield leads the Behavioral Sciences Unit at UNSW and Sydney Children's Hospital, one of the largest pediatric cancer survivorship research groups in the world.  Together, we explore the psychological and emotional challenges families face when navigating new treatment options, clinical trials, and difficult medical decisions. Dr. Wakefield shares her insights on ethical best practices, shared decision-making, and the evolving landscape of pediatric cancer care—ensuring that families receive not only medical support but also the guidance and resources needed for their well-being.  Key Topics Covered:- The intersection of pediatric cancer treatment, psychology, and hope  - How families process and make decisions about clinical trials  - The impact of new medical technologies on patient experiences  - Supporting children and parents through the hardest moments  - The global disparities in pediatric cancer treatment and efforts to bridge the gap  This thought-provoking conversation is a must-listen for anyone passionate about advancing pediatric cancer research and supporting families in the fight.  Support the mission visit us at:  https://www.cannonballkidscancer.org to make a gift and help fund innovative research.----------------------------------Podcast Produced by Hi Hello Labs: Website: https://www.hihellolabs.com/

“You can give someone a survivorship care plan, but just giving them doesn't mean that it's going to happen. Maybe there's no information about family history. Or maybe there's information and there's quite a bit of family history, but there's nothing that says, ‘Oh, they were ever had genetic testing,' or ‘Oh, they were ever referred.' So the intent is so good because it's to really take that time out when they're through with active treatment and, you know, try to help give the patient some guidance as to what to expect down the line,” Suzanne Mahon, DNS, RN, AOCN®, AGN-BC, FAAN, professor emeritus at Saint Louis University in Missouri, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a conversation about breast cancer survivorship.   Music Credit: “Fireflies and Stardust” by Kevin MacLeod  Licensed under Creative Commons by Attribution 3.0   Earn 0.75 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by March 14, 2027. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.  Learning outcome: Learners will report an increase in knowledge related to breast cancer survivorship.  Episode Notes   Complete this evaluation for free NCPD.   Previous ONS Podcast™ site-specific episodes: Episode 350: Breast Cancer Treatment Considerations for Nurses  Episode 348: Breast Cancer Diagnostic Considerations for Nurses  Episode 345: Breast Cancer Screening, Detection, and Disparities  ONS Voice articles: Breast Cancer Prevention, Screening, Diagnosis, Treatment, Side Effect, and Survivorship Considerations  Improve Management of Common Symptoms for Breast Cancer Survivors  Nursing Considerations for Breast Cancer Survivorship Care  Sexual Considerations for Patients With Cancer ONS books:  Breast Care Certification Review (second edition)  Guide to Breast Care for Oncology Nurses  ONS course: Breast Cancer Bundle  ONS Learning Libraries:  Breast Cancer  Genomics and Precision Oncology  Nurse Navigation  Oral Anticancer Medication   Survivorship  ONS Guidelines™ and Symptom Interventions:  Anxiety  Cognitive Impairment  Depression  Fatigue  Clinical Journal of Oncology Nursing article: Survivorship Care: More Than Checking a Box  Clinical Journal of Oncology Nursing supplement: Survivorship Care  American Cancer Society:  Cancer Treatment and Survivorship Facts and Figures  Survivorship: During and After Treatment  Livestrong® Program at the YMCA  National Comprehensive Cancer Network  National Cancer Institute Breast Cancer—Patient Version    To discuss the information in this episode with other oncology nurses, visit the ONS Communities.   To find resources for creating an ONS Podcast Club in your chapter or nursing community, visit the ONS Podcast Library.  To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org.  Highlights From This Episode  “I think the biggest thing is to really communicate is that people are living with breast cancer for a long, long periods of time, and a lot of that with really good quality overall.” TS 4:07   “As a general rule, they're going to be seen by the breast surgeon probably every four to six months for a while. After about five years, a lot of times people are ready to say, ‘Okay, annually is okay.' And eventually they may let that drop off. But it also depends on did they have a mastectomy? Did they have breast conserving surgery? And then if they had reconstruction with an implant, how often do they see the plastic surgeon? Because they need to check integrity of the implant. So those schedules are really individualized.” TS 13:24  “When you think about long-term effects, I think you need to kind of think about that survivors can have both acute and long-term chronic effects. And a lot of that depends on the specifics of the treatment they had. I think as oncology nurses, we're used to, ‘We give you this chemotherapy or this agent, and these are the side effects.'” TS 15:36  “The diet issues are huge. And I think we are slow to refer to the dietician, you know, you can get them a couple of consults and because you're saying to them, ‘This is really important. We need you to lose weight or we need you to eat more of this.' Ideally, fruits and vegetables are going to be about half of your plate. And what's the difference between a whole grain and not, less processed foods, making sure that they're getting enough protein. And then once again, really kind of making sure that they're not taking a lot of supplements and extra stuff because we don't really understand all that fully and it could be harmful.” TS 34:53  “Breast cancer is a long, long journey, and I think you should never underestimate the real difference that nurses can make. I think they can ask those tough questions. And I think ask the questions that are important to patients that patients may be reluctant to ask. I think giving patients permission to talk about those less-talked-about symptoms and acknowledge that those symptoms are real and that there are some strategies to mitigate those symptoms.” TS 42:28   

In April 2024, Meharry Medical College received an ORAU Innovation Partnership Grant to help students from Historically Black Colleges and Universities in the Nashville area attended Meharry's annual Cancer Survivorship Summit. IPG grants, offered through ORAU's Research and University Partnerships Office, are designed to strengthen relationships between university consortium members and ORAU subject matter experts. The summit was a day-long event focused on sharing information about cancer risks, research, and prevention and early detection, as well as provide opportunities for community members to get needed health and medical screenings. In this conversation, host Michael Holtz talks with the team from Meharry that helped make the summit possible, including Tammy Henderson, Ph.D., vice president in the Office of Strategic Initiatives and Innovation at the Meharry School of Medicine; Kirsten George, health careers pathway program manager in the Department of Family and Community Medicine; and Donald Alcendor, Ph.D., associate professor in the Department of Microbiology, Immunology and Physiology. Also joining the conversation is Robert Briggs, a senior majoring in business management at Lemoyne-Owen College, who one of the students able to attend the summit because of the ORAU IPG grant.

In this episode, we speak with Ann Roseman, a melanoma survivor since 2020, who shares her personal journey with cancer and how it shaped her mission to advocate for sun safety. Ann's background in Human Development and Family Studies, combined with her experience as a Certified Child Life Specialist, allowed her to make a meaningful impact in healthcare settings, creating programs and supporting families through tough times. After retiring from Hospice of the Valley, Ann turned her focus to preventing melanoma in her community, volunteering with AIM at Melanoma and educating the public about sun safety.Ann also serves on the committee for the upcoming Phoenix Steps Against Melanoma walk, and her work continues to empower others to take proactive steps in protecting their skin. Tune in to hear about Ann's personal story, her passion for prevention, and how she's working to make a difference in the “Valley of the Sun.” Plus, we'll hear about her volunteering work with Maggie, her certified therapy dog, bringing joy and support to children and families at local libraries.About Our HostSamantha Siegel, MDDr. Samantha Siegel is an internist at Kaiser Permanente and the current director of Cancer Survivorship at Kaiser San Francisco. She has survived relapsed/refractory Hodgkin's Lymphoma, including an autologous bone marrow transplant in June 2022. This has made her passionate about cancer survivorship, integrative medicine and personal narrative impacting the illness experience. She is a public speaker advocating strongly for cancer care.Dr. Siegel is pioneering a longitudinal cancer survivorship care model, beginning at diagnosis, that can be replicated in other healthcare systems. She is focused on elevating cancer survivorship to a distinct, multidisciplinary board certification status.Dr. Siegel lives in Davis with her husband, three kids and energetic dog. She enjoys outdoor activities, plant-based living and any occasion to dance.If you have questions, feedback, or topic ideas for upcoming episodes, please e-mail us at: engageus@AIMatMelanoma.org.

In honor of National Nutrition Month, let's focus on the undeniable power of nutrition in survivorship and how you can tap into all its benefits. Maybe you're not sure what those benefits are, so in this episode Cathy offers a broad, general view of how nutrition supports optimal breast cancer survivor health and helps potentially minimize recurrence risk.__________________________Click here to apply to my Peaceful Plate program! Get my FREE guide The Five Foods Survivors Should Eat; click here!Follow me on Instagram @hormone.breastcancer.dietitian

In this episode: financial Independence, health and nutrition, cancer survival, opportunity funds, living in the present with Diandra Denier-FieldsEpisode SummaryIn this episode, Adam welcomes Diandra Denier-Fields, a nutritional scientist and two-time cancer survivor. Diandra shares her journey towards Financial Independence, the importance of prioritizing health, and how her experiences with cancer have shaped her current mission to help others. Adam & Diandra also discuss the concept of opportunity funds, living in the moment, and the significance of making informed health choices.Guest BioDiandra Denier-Fields is a nutritional scientist with a PhD in nutritional sciences and a minor in epidemiology from the University of Wisconsin. As a two-time cancer survivor, she is passionate about helping others navigate their health journeys through her brand, Cancer Free Haven, which provides resources and support for cancer survivors and those at risk.Resources & Books Mentioned"Your Money or Your Life" by Vicki Robin"The Simple Path to Wealth" by JL CollinsGuest Contact Information“That Science Couple”: https://thatsciencecouple.com/“Cancer Free Haven”: https://cancerfreehaven.com/“Cancer Free Haven” Instagram: https://www.instagram.com/cancer.free.haven/Key TakeawaysFinancial Independence is about creating a life you love and prioritizing experiences over material possessions.Investing in your health and making informed dietary choices can significantly impact your well-being.Opportunity funds provide flexibility and can help you take advantage of life experiences without jeopardizing your financial future.Living in the present and cherishing moments is essential, especially in the face of uncertainty and health challenges.It's important to challenge common nutritional myths and focus on a balanced diet that supports overall health.Building a supportive community for cancer survivors is crucial for empowerment and shared knowledge.PS: Introducing the…

Advancements in medical technology are transforming cancer screening, with multicancer early detection (MCED) testing leading the way. Dr. Charles Vega, a Clinical Professor of Family Medicine at the University of California (UC) Irvine, is currently serving as chair of i3 Health's three-part microlearning series, Optimizing Cancer Screening with MCED Technologies: From Science to Practical Application. With new advances in developing MCED testing and implementing it into practice, Dr. Vega sat down with us again to share additional insights from Module 2 of the activity, including the value of MCED testing for cancer survivors and ongoing trials investigating MCEDs that he's looking forward to seeing results of in the near future. Afterwards, stay tuned to hear the full activity and learn how to claim CME credit. Click here to claim your CME credit: https://bit.ly/41rS14I

In this episode, we sit down with Noa Curtis, LCSW, APHSW-C, an outpatient oncology social worker at the Providence Cancer Institute in Portland, Oregon. Noa specializes in palliative care and provides holistic support to cancer patients and their families from diagnosis through survivorship or end of life. They discuss their approach to palliative care, focusing on self-advocacy, meaning-making, and self-compassion as vital components of the healing journey. With a deep commitment to supporting patients emotionally and psychologically, Noa also shares insights into their role in enhancing quality of life, managing difficult transitions, and advocating for patient-centered care. Tune in for an insightful conversation on the critical role of social work in oncology and palliative care. About Our Host Samantha Siegel, MDDr. Samantha Siegel is an internist at Kaiser Permanente and the current Direct of Cancer Survivorship at Kaiser San Francisco. She has survived relapsed/refractory Hodgkin's Lymphoma, including an autologous bone marrow transplant in June 2022. This has made her passionate about cancer survivorship, integrative medicine and personal narrative impacting the illness experience. She is a public speaker advocating strongly for cancer care. Dr. Siegel is pioneering a longitudinal cancer survivorship care model, beginning at diagnosis, that can be replicated in other healthcare systems. She is focused on elevating cancer survivorship to a distinct, multidisciplinary board certification status. Dr. Siegel lives in Davis with her husband, three kids and energetic dog. She enjoys outdoor activities, plant-based living and any occasion to dance. If you have questions, feedback, or topic ideas for upcoming episodes, please e-mail us at: engageus@AIMatMelanoma.org.

Commentary by Dr. Jan Leerink.

Join us for an empowering and insightful conversation as Dr. Jennie Berkovich sits down with Dr. Amy Comander, a leading breast oncologist and advocate for patient-centered care. In this episode, Dr. Comander shares her expertise on the latest advancements in breast cancer detection, treatment, and survivorship. Discover how personalized medicine and multidisciplinary care are revolutionizing outcomes for breast cancer patients. Dr. Comander also delves into the critical role of lifestyle medicine—including exercise, nutrition, and mindfulness—in promoting healing and resilience. With her unique perspective as a passionate runner and physician, Dr. Comander draws inspiring parallels between running and the cancer journey, offering hope and practical advice for patients and their families navigating a diagnosis. Whether you're a healthcare professional, patient, or advocate, this episode will leave you informed, inspired, and ready to run the race toward better cancer care. Don't miss it! Dr. Amy Comander specializes in the care of women with breast cancer.  Dr. Comander is Medical Director of the Mass General Cancer Center in Waltham, where she also serves as Director of Breast Oncology and Cancer Survivorship at the Mass General Cancer Center in Waltham and at Newton Wellesley Hospital. She is an Instructor in Medicine at Harvard Medical School. She received her undergraduate degree and a master's degree in Neuroscience at Harvard University. She received her medical degree at Yale University School of Medicine. She completed her Internal Medicine residency training and Hematology-Oncology fellowship training at Beth Israel Deaconess Medical Center and Harvard Medical School. She is board certified in Hematology and Medical Oncology, and she is a Diplomat of the American Board of Lifestyle Medicine. _________________________________________________ Sponsor the JOWMA Podcast! Email digitalcontent@jowma.org Become a JOWMA Member! www.jowma.org Follow us on Instagram! www.instagram.com/JOWMA_org Follow us on Twitter! www.twitter.com/JOWMA_med Follow us on Facebook! https://www.facebook.com/JOWMAorg Stay up-to-date with JOWMA news! Sign up for the JOWMA newsletter! https://jowma.us6.list-manage.com/subscribe?u=9b4e9beb287874f9dc7f80289&id=ea3ef44644&mc_cid=dfb442d2a7&mc_eid=e9eee6e41e

In this episode, we speak with Brian Jin, LCSW, a psychotherapist specializing in Meaning-Centered Psychotherapy (MCP) at Yale New Haven Health's Smilow Cancer Hospital. Brian shares his journey and experience supporting cancer patients through MCP, an evidence-based therapy designed to help individuals find meaning and hope amidst illness. He discusses how this therapeutic approach can empower patients, help them navigate the emotional challenges of cancer, and maintain vitality throughout their treatment. Brian's expertise also extends to his work with support groups for lung cancer, pancreatic cancer, and brain tumor patients. Tune in as we explore the power of meaning and purpose in sustaining hope and resilience during cancer treatment. About Our Host Samantha Siegel, MDDr. Samantha Siegel is an internist at Kaiser Permanente and the current Director of Cancer Survivorship at Kaiser San Francisco. She has survived relapsed/refractory Hodgkin's Lymphoma, including an autologous bone marrow transplant in June 2022. This has made her passionate about cancer survivorship, integrative medicine and personal narrative impacting the illness experience. She is a public speaker advocating strongly for cancer care. Dr. Siegel is pioneering a longitudinal cancer survivorship care model, beginning at diagnosis, that can be replicated in other healthcare systems. She is focused on elevating cancer survivorship to a distinct, multidisciplinary board certification status. Dr. Siegel lives in Davis with her husband, three kids and energetic dog. She enjoys outdoor activities, plant-based living and any occasion to dance. If you have questions, feedback, or topic ideas for upcoming episodes, please e-mail us at: engageus@AIMatMelanoma.org.

In a conversation with CancerNetwork®, Rachel A. Millstein, PhD, MHS; Loren Winters, NP; and Amy Comander, MD, discussed their article titled Implementing a Multidisciplinary Lifestyle Medicine Clinic for Cancer Survivorship, which was published in the November 2024 issue of ONCOLOGY®. The authors detailed the implementation of a novel oncology-based multidisciplinary lifestyle medicine clinic that may help enhance the quality of life (QOL) among survivors of cancer. Millstein is a psychologist in the Behavioral Medicine Program and an assistant professor in the Department of Psychiatry at Massachusetts General Hospital. Winters is an oncology nurse practitioner and assistant director of the Lifestyle Medicine Program at Massachusetts General Hospital. Comander is the medical director of Mass General Cancer Center-Waltham, director of the Breast Oncology Program at Newton-Wellesley Hospital, and director of the Lifestyle Medicine Program at Massachusetts General Hospital. Millstein outlined the rationale for this publication on the development of a multidisciplinary lifestyle medicine clinic, highlighting a need to boost general awareness and support for lifestyle medicine consultations and health behavior change in cancer survivor care. Winters then explained how the multidisciplinary clinic works in alignment with 6 key pillars of lifestyle medicine, as team members aim to promote physical activity, plant-predominant diets, restorative sleep, stress management, avoidance of risky substances, and social connections to enhance QOL among cancer survivors. Additionally, Comander highlighted how the lifestyle medicine program optimizes health and well-being by matching patients to the specific services they require, which may include the help of team members such as board-certified physicians, nurse practitioners, registered dietitians, and clinical psychologists. Millstein and Winters then detailed the improvements in health behaviors associated with 2 patient cases at their program, demonstrating the potential benefits of implementing broad and diverse lifestyle medicine tools in oncology-supportive care. Looking ahead, Comander described the importance of addressing gaps in education, a lack of programs focused on areas such as weight management, and other barriers to the implementation of lifestyle medicine in oncology care. Finally, each author expressed her hope to see more colleagues, clinics, and programs incorporate lifestyle medicine as part of elevating QOL among survivors of cancer. The authors invite listeners to contact them if they would like to find ways to implement lifestyle medicine in their respective centers.

I am at a point now where I have follow-up breast imaging. I suspect everything will be normal. I considered rescheduling the upcoming appointments related to my breast cancer until after the holiday season.  A few common thoughts that I bring up in this episode: Survivorship can be difficult, even when things are going well Everything has the potential to be something in the body after a history of breast cancer Testing (a breast MRI) in December has the potential to distract me from what is most important at this time of the year Going to doctor appointments is not how I want to spend my December Strategies to manage stress are essential Subscribe, rate, and review the Breast Cancer Life podcast.  The content of this podcast is not intended to substitute professional medical advice, diagnosis, or treatment. Always consult a healthcare professional regarding your healthcare questions and concerns.  This podcast contains opinions of the host. LET'S CONNECT: connect@breastcancerlife.org 

Cancer impacts millions of Americans each year, but there's often a misconception the journey of cancer care ends when treatment ends. In reality, cancer survivorship is a lifelong experience. And there's a multifaceted impact of a cancer diagnosis on our loved ones and ourselves. What are the challenges of navigating life post-cancer and treatment? And how can we utilize support in this journey? Donald Rosenstein, MD, psychiatrist and director of the Comprehensive Cancer Support Program at UNC-Chapel Hill, explores with us the emotional effects of survivorship, including grief, fear of recurrence, changes in self-image, and the complexities of parenting and relationships. He also emphasizes the importance of emotional support, community, and patient advocacy in the ongoing journey of cancer survivorship.

Commentary by Dr. Beshay Zordoky.

EVEN MORE about this episode!Join us for an inspiring conversation with Karla Mans Giroux, co-director of the Radical Remission Project, as she reveals the powerful secrets behind radical remission. Discover life-changing stories of individuals who conquered cancer by combining conventional medicine with emotional, lifestyle, and spiritual healing.Learn about Dr. Kelly Turner's groundbreaking research on the ten factors common among over 1,500 survivors, including the role of self-advocacy, emotional well-being, and the mind-body connection. This episode is filled with hope and practical insights that empower cancer patients—and anyone facing chronic illness—to take control of their healing journey.With tips on diet, exercise, and intuition, Karla shows how healing is a deeply personal, holistic experience. Plus, hear from a survivor who healed through a unique blend of medical and holistic practices. Don't miss this chance to explore the life-altering power of radical remission!Guest Biography:Karla Mans Giroux is the Co-Director of the Radical Remission Project, Co-Founder of Health Navigators, and a holistic cancer health coach, educator, and speaker. A metastatic breast cancer (MBC) survivor thriving with No Evidence of Disease since 2016, Karla was originally diagnosed in 2003 and faced a recurrence in 2014.Determined to live beyond the odds, Karla embraced a holistic healing journey, achieving remission and inspiring others to do the same. Certified by the Wisdom of the Whole Coaching Academy, the Radical Remission Project, and NBHWC, she co-founded Health Navigators in 2020, creating a Virtual Cancer Wellness Community.As a Radical Remission workshop instructor, podcast co-host, and health coach, Karla shares the transformative power of Radical Remission healing factors, empowering others to take charge of their health and well-being.Episode Chapters:(0:00:01) - What Is Radical Remission?(0:08:48) - Integrative Oncology and Cancer Survivorship(0:24:53) - Navigating Resistance in Cancer Care(0:32:01) - The Power of Mind-Body Healing(0:40:19) - Diet, Intuition, and Emotional Healing(0:55:38) - Improving Quality of Life Through Workshops(1:05:33) - The Purpose of Incarnation and Cancer(1:11:40) - Empowering Conversations on Fighting CancerPlease join Julie next week with your question.Thursdays at 8pm ET, 7pm CT, 5pm PT.https://askjulieryanshow.comAnd, please leave a five-star review and subscribe so you can hear all the new episodes.Sponsors & RecommendationsDisclaimer: This show is for informational purposes only. It is not intended to be medical, psychological, financial or legal advice. Please contact a licensed professional. The Ask Julie Ryan show, Julie Ryan, and all parties involved in producing, recording and distributing it assume no responsibility for listener's actions based on any information heard on this or any Ask Julie Ryan shows or podcasts.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Lynn Gooden, BSN, RN, ONN-CG, Community Health Network MD Anderson Cancer Center, Indianapolis, IN and Cassie Osborne, MSN, RN, OCN, ONN-CG, Community Health Network MD Anderson Cancer Center, Indianapolis, IN Recorded on November 14, 2024 Lynn Gooden, BSN, RN, ONN-CG Oncology Navigation and Survivorship Manager Oncology Navigation Community Health Network MD Anderson Cancer Center Indianapolis, IN Cassie Osborne, MSN, RN, OCN, ONN-CG Oncology Nurse Navigator Oncology Navigation-Hematology/Sarcoma/Brain/Skin Community Health Network MD Anderson Cancer Center Indianapolis, IN Join us for this important episode, as Lynn Gooden and Cassie Osborne, nurses from the Community Health Network MD Anderson Cancer Center in Indianapolis, discuss mental health challenges faced by survivors of cancer, including the impact of long-term and late effects. They explore how a multidisciplinary team can address both physical and psychosocial needs, and caregiver involvement in decision-making and support. Resources are also highlighted for healthcare professional education, along with support resources for survivors and caregivers to enhance survivorship. Tune in to today for this insightful discussion! This episode is supported by Genentech, A Member of the Roche Group.

In this podcast episode, we talk to Liz Muenks, a licensed psychologist and director of the Onco-Psychology Program at the University of Kansas Cancer Center. We discuss the psychosocial and emotional challenges faced by patients undergoing CAR T-cell therapy, a groundbreaking treatment for cancer, and how these experiences affect both patients and caregivers.Liz explains that patients typically enter CAR T-cell therapy after exhausting other treatment options, which leads to a heavy emotional burden. Many patients feel like they've "failed" previous treatments, a term that Liz finds problematic but acknowledges is often used. The pre-treatment phase is already filled with anxiety, depression, and fear. While some patients approach CAR T with hope and optimism, others carry a deep skepticism based on their past experiences. Liz notes that there are optimists, pessimists, and realists among patients, each bringing a different mindset to this journey.Liz highlights the societal pressure on cancer patients to maintain a positive attitude, which can add stress. She dispels the myth that a positive mindset is required to beat cancer, emphasizing that embracing all emotions, including fear and worry, is crucial to managing the cancer journey. While uncontrolled anxiety or depression can negatively impact outcomes, Liz reassures that patients can still succeed in their treatment even with emotional ups and downs.The conversation also touches on the unique side effects of CAR T-cell therapy, which differs from traditional treatments like bone marrow and stem cell transplants. While patients often feel relieved that the chemotherapy before CAR T is less intense, they are faced with neurological risks and the potential for serious side effects like cytokine release syndrome. However, these severe side effects affect a minority of patients.Caregivers, Liz stresses, play a vital role, especially as CAR T is increasingly being done on an outpatient basis. She advises caregivers to lean on their medical teams for support and never hesitate to ask questions. Caregivers often feel immense pressure, but Liz encourages them to recognize that they are not alone in this journey. Support networks include therapy groups, on line resources such as nbmtLINK.org (and many others) and on-call specialists , all available, offering caregivers support in sharing their burdens and finding reputable resources and guidance.Finally, Liz discusses the psychological challenges that linger after CAR T-cell therapy, especially the anxiety of cancer recurrence. Many patients struggle to move forward, constantly worrying about how much time they have before the disease returns. While some can compartmentalize these fears, others need ongoing psychological support. Liz also shares stories of patients who were initially hesitant about CAR T due to difficult past treatments but later experienced positive outcomes, reflecting the progress being made in this groundbreaking cancer therapy.This season is made possible thanks to our sponsors:Kite, a Gilead company: http://www.kitepharma.com/and Bristol Myers Squibb's CAR T support services program:https://www.celltherapy360.com/ Follow the nbmtLINK on Instagram! https://www.instagram.com/nbmtlink/Or visit our website at https://www.nbmtlink.org/

On the show today: Lisa Simms Booth is Executive Director at The Smith Center for the Healing Arts and former Senior Director for Patient and Public Engagement at The Biden Cancer Initiative. She is such an extraordinary human being who've I've wanted her on my show for such a long time and, well, here she is. Lisa has this extraordinary way to define and extoll the virtues of cancer survivorship, how far we've come in the last half-century, lessons learned from the pandemic for Nonprofit Leadership, cancer screenings, prevention, and more.FUN FACT: The Smith Center occupies a unique place in my life as they hosted one of the very first Stupid Cancer Happy Hour events in DC in 2007. It's a great place, so if you live in the DC area, be sure to check them out.SIDENOTE: For the cheap seats in the back, many of you may recognize The Smith Center from Episode 81 with my guest, Dr. Julia Rowland, who serves as their Senior Strategic Advisor. (Julia is also the Founding Director of The National Cancer Institute's Office of Cancer Survivorship. You can hear her share her story as one of the contributors to The Cancer Mavericks, our eight-part docu-series about the history of cancer survivorship.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

This week Bobbi Conner talks with MUSC's Dr. Anca Dumitriu about childhood cancer survivorship in S.C.

Raul Chavez is an 18-year kidney cancer survivor with an unclassifiable diagnosis. In conversation with host Annamaria Scaccia, Raul shared the emotional and mental toll of living life in three-month intervals, always wondering if he'll receive a new lease on life with each scan. Raul described the post-traumatic stress he endured after his diagnosis and being in "survivor mode" during the first five years. Visit kidneycancer.org for more support and resources. Hosted on Acast. See acast.com/privacy for more information.

Two breast cancer survivors offer their unique insights about resilience and long-term health following their breast cancer diagnoses and treatments. They share their experience managing life's challenges during and after a major health battle, and what it means to truly thrive beyond breast cancer.Host:Johanna Gomez, Breast Cancer SurvivorGuests: Clara Pablo, Breast Cancer SurvivorTamara Rodriguez, Breast Cancer Survivor

This week Bobbi Conner talks with MUSC's Dr. Abi Siva about follow-up care and support for breast cancer survivors.

In this episode, Efstratios Koutroumpakis discusses a critical study on autonomic dysfunction among adult survivors of childhood cancer, highlighting its prevalence and functional significance compared to community controls. The research underscores the complex etiologies of autonomic dysfunction linked to cancer treatments and stresses the importance of early detection and standardized testing to improve cardiovascular health and quality of life in this growing survivor population.

In this episode, Dr. Sonia Shah explores a study from Australian researchers that evaluates the effectiveness of a polygenic risk score in predicting heart failure among cancer survivors. While the score enhanced prediction compared to age and sex alone, it did not significantly outperform existing modifiable risk factors, highlighting the need for more comprehensive models that account for unique risks faced by cancer patients.

In this episode of Walk, Don't Run to the Doctor, Miles Hassell MD focuses on cancer survivorship and prevention, emphasizing the importance of lifestyle choices. Key takeaways include: Lifestyle and Cancer: Diet, exercise, and weight management are as crucial as conventional cancer treatments like surgery or chemotherapy. Dietary Recommendations: The Mediterranean diet is highlighted for its benefits in reducing cancer recurrence, improving survival rates, and enhancing quality of life.  Though the available research points to the Mediterranean diet being the most widely studied, any omnivorous, whole foods diet is practical here. Exercise & Physical Activity: Regular movement, even brief daily exercises, helps reduce cancer recurrence, boosts mood, and may improve treatment outcomes. Alcohol & Cancer: Moderate alcohol consumption may have health benefits, but overconsumption increases cancer risk. Weight Management: Maintaining a healthy weight is vital for cancer prevention and survivorship, as excess fat correlates with worse outcomes. Future Resources: A comprehensive cancer survivorship program will be available soon, with a detailed guide on managing cancer through lifestyle choices. Tune in for expert insights and practical steps to enhance cancer outcomes through lifestyle adjustments! The purpose of GreatMed.org is to enhance the doctor/patient relationship.  We encourage clinicians to talk with their patients about these points, and patients to talk with their care teams.  This information should not replace medical care, but enhance it. The American Cancer Society Medical and Editorial Content Team. (2023, December 15). Body Weight and Cancer Risk. The American Cancer Society. https://www.cancer.org/cancer/risk-prevention/diet-physical-activity/body-weight-and-cancer-risk.html Wang, F., et al. (2020). Adherence to dietary recommendations among long-term breast Cancer Survivors and Cancer Outcome Associations. Cancer Epidemiology, Biomarkers & Prevention, 29(2), 386–395. https://doi.org/10.1158/1055-9965.EPI-19-0872 Ergas, I. J., et al. (2021). Diet quality and breast cancer recurrence and survival: The pathways study. JNCI cancer spectrum, 5(2), pkab019. https://doi.org/10.1093/jncics/pkab019 Castro-Espin, C., et al. (2023).Association of Mediterranean diet with survival after breast cancer diagnosis in women from nine European countries: results from the EPIC cohort study. BMC Med 21, 225 (2023). https://doi.org/10.1186/s12916-023-02934-3 Zhang, W., et al. (2023). Adherence to healthy dietary patterns and glioma: a matched case-control study. Nutrients, 15(23), 4886. https://pubmed.ncbi.nlm.nih.gov/38068744/ Hong, S., et al. (2020). Alcohol consumption and the risk of prostate cancer: a dose-response meta-analysis.  Nutrients, 12(8), 2188. https://www.mdpi.com/2072-6643/12/8/2188 Estruch, R., et al. (2022). Associations between Low to Moderate Consumption of Alcoholic Beverage Types and Health Outcomes: A Systematic Review. Alcohol and Alcoholism, 57(2), 176–184, https://doi.org/10.1093/alcalc/agab082 Buljeta, I., et al. (2023). Beneficial effects of red wine polyphenols on human health: comprehensive review. Current Issues in Molecular Biology, 45(2), 782–798. https://doi.org/10.3390/cimb45020052  

In this episode of Game Over: c*ncer, hosts Val Solomon and Dana Nichols sit down with a clinical psychologist from AdventHealth Orlando, Dr. Carrasco, to discuss the often-overlooked challenges that pediatric cancer survivors face once treatment ends. They explore the emotional, physical, and cognitive adjustments children and their families must navigate and how the transition from patient to survivor can be both a relief and a new source of anxiety. From dealing with survivor's guilt to managing social reintegration, this episode offers deep insights into the complexities of life after cancer. Listeners will learn how they can support these young survivors as they find their new normal.Connect with Dr. Carrasco:https://www.instagram.com/cassccarrasco/How YOU can make a difference: https://cannonballkidscancer.org/other-ways-to-activate/Connect with Dana: https://www.linkedin.com/in/danaknichols/Connect with Val: https://www.linkedin.com/in/valerie-solomon-516b50b8/Learn more about the Cannonball Kids cancer Foundation: https://cannonballkidscancer.org/

What is supportive care or supportive oncology? What is cancer-related distress? How might NET patients benefit from supportive care? Yale oncologist Dr. Maryam Lustberg suggests strategies to manage cancer-related fatigue, diarrhea, nausea, mouth sores, peripheral neuropathy, distress, anxiety, and anxiety. She also addresses considerations for fertility and sexual health.MEET DR. MARYAM LUSTBERGDr. Maryam Lustberg is an American breast oncologist. She is the Director of The Breast Center at Smilow Cancer Hospital and Chief ofBreast Medical Oncology at Yale Cancer Center. Dr. Lustberg previously served as the Medical Director of Cancer Supportive Care Services atOhio State's Comprehensive Cancer Center. She is the Immediate Past President of the Multinational Association of Supportive Care in Cancer. She is also an Associate Editor for the Journal of Cancer Survivorship.TOP TEN QUESTIONS ABOUT SUPPORTIVE CARE: What is supportive care in cancer (or supportive oncology)? What is survivorship? How do these concepts apply to the NET community?What is the 1st step for patients to get supportive care?What are the most common treated-related adverse events or side effects? What are risk factors for them? (Will all patients experience all potential side effects?)What causes cancer-related fatigue (CRF)? What are some strategies to manage cancer-related fatigue?What are some strategies to manage diarrhea?What are some strategies to manage nausea?What are some strategies to manage mouth sores?What is peripheral neuropathy? When do patients experience it and what can be done to prevent it?What should patients understand about sexual health and fertility?How can psychosocial needs such as distress, anxiety, and depression be addressed and supported?For more information, please visit https://www.lacnets.org/podcast/37. For more information, visit LACNETS.org.

- Overview of Cancer Survivorship - Managing Post Treatment Side Effects/Late Effects - Quality-of-Life Concerns - Fear of Recurrence - Finding Your New Normal - The Importance of Treatment Summaries and Encounter Notes - Follow-Up with Your Oncologist and Primary Care Doctor, Including Discussion of Health Screening and Concerns - Guidelines to Prepare for Telehealth/Telemedicine Appointments, Including Technology, Prepared List of Questions, and Discussion of OpenNotes - Questions for Our Panel of Experts

- Overview of Cancer Survivorship - Managing Post Treatment Side Effects/Late Effects - Quality-of-Life Concerns - Fear of Recurrence - Finding Your New Normal - The Importance of Treatment Summaries and Encounter Notes - Follow-Up with Your Oncologist and Primary Care Doctor, Including Discussion of Health Screening and Concerns - Guidelines to Prepare for Telehealth/Telemedicine Appointments, Including Technology, Prepared List of Questions, and Discussion of OpenNotes - Questions for Our Panel of Experts

- Overview of Cancer Survivorship - Managing Post Treatment Side Effects/Late Effects - Quality-of-Life Concerns - Fear of Recurrence - Finding Your New Normal - The Importance of Treatment Summaries and Encounter Notes - Follow-Up with Your Oncologist and Primary Care Doctor, Including Discussion of Health Screening and Concerns - Guidelines to Prepare for Telehealth/Telemedicine Appointments, Including Technology, Prepared List of Questions, and Discussion of OpenNotes - Questions for Our Panel of Experts

- Overview of Cancer Survivorship - Managing Post Treatment Side Effects/Late Effects - Quality-of-Life Concerns - Fear of Recurrence - Finding Your New Normal - The Importance of Treatment Summaries and Encounter Notes - Follow-Up with Your Oncologist and Primary Care Doctor, Including Discussion of Health Screening and Concerns - Guidelines to Prepare for Telehealth/Telemedicine Appointments, Including Technology, Prepared List of Questions, and Discussion of OpenNotes - Questions for Our Panel of Experts

Drs. Hope Rugo, Diana Lam, Sheri Shen, and Mitchell Elliot discuss key strategies and emerging technology in early-stage breast cancer survivorship, including mitigating risk through lifestyle modification, surveillance for distant recurrence, and optimization of breast imaging. TRANSCRIPT  Dr. Hope Rugo: Hello, I'm Dr. Hope Rugo, your guest host of the ASCO Daily News Podcast today. I'm a professor of medicine and director of breast oncology and clinical trials education at the University of California San Francisco's Comprehensive Cancer Center. I'm also an associate editor of the ASCO Educational Book.   There are currently about 4 million breast cancer survivors in the United States, according to the American Cancer Society, and this number is expected to rise as more women are being diagnosed at early stages of this disease, thanks to advances in early detection and the delivery of more effective adjuvant and neoadjuvant treatment leading to successful outcomes.  In today's episode, we'll be discussing current and emerging clinical strategies for the survivorship period, focusing on a multidisciplinary approach. Joining me for this discussion are Drs. Mitchell Elliott, Sherry Shen, and Diana Lam, who co-authored, along with others, a recently published article in the 2024 ASCO Educational Book titled, “Enhancing Early-Stage Breast Cancer Survivorship: Evidence-Based Strategies, Surveillance Testing, and Imaging Guidelines.”  They also addressed this topic in an Education Session presented at the recent ASCO Annual Meeting. Dr. Elliott is a drug development fellow and clinician scientist trainee at the Princess Margaret Cancer Center in Toronto, Canada. Dr. Sherry Shen is a breast oncologist and assistant attending at the Memorial Sloan Kettering Cancer Center in New York. Dr. Diana Lam is a breast radiologist and associate professor at the University of Washington Fred Hutchinson Cancer Center in Seattle.  Our full disclosures are available in the transcript of this episode.  It's great to have you all on the podcast today. Thank you for being here. Dr. Mitchell Elliott: Thank you so much.  Dr. Sherry Shen: Thank you.  Dr. Hope Rugo: Let's go into the meat of the article now and try to provide some interesting answers to questions that I think come up for clinicians all the time in practice. Your article points out that addressing the challenges in early-stage breast cancer survivorship requires a comprehensive, patient-centered approach, focusing on mitigating risk through lifestyle modification, surveillance for distant recurrence, and optimization of breast imaging.   Dr. Shen, surveillance can facilitate the early detection of recurrence, but ultimately the goal is to prevent recurrence. Lifestyle modifications are a key component of survivorship care, and there are many interventions in this context. Could you summarize the best approaches for mitigating risk of breast cancer recurrence through lifestyle modification and how we might accomplish that in clinical practice? Dr. Sherry Shen: Absolutely. This is a question that we get asked a lot by our breast cancer patients who are so interested in what changes they can make within their lifestyle to improve their breast cancer outcomes. I always tell them that there are three main things, three main lifestyle factors that can improve their breast cancer outcomes.  Firstly, enough physical activity. So the threshold for physical activity seems to be around 150 minutes of a moderately vigorous level per week. So moderately vigorous means something that gets the heart rate up, like walking quickly on rolling hills, for example. Or patients can do a vigorous level of physical activity for at least 75 minutes per week. Vigorous meaning playing a sport, swimming, for example, running, something that really gets the heart rate up.   The second really important lifestyle modification is limiting alcohol use. Keeping alcohol to less than 4 to 7 drinks per week is particularly important for breast cancer outcomes, especially in women who are postmenopausal and have hormone receptor positive diseases. That's where the strongest connection is seen. Lastly, maintaining a healthy weight. We know that women who gain more than 5% to 10% of their diagnosis body weight have a higher risk of breast cancer recurrence and worse breast cancer outcomes. That, of course, is easier said than done, and it's primarily through dietary modifications.  I always tell women that in terms of specific things in the diet, it's really hard to study at a population level because diets vary so much between patients. But what is really important is consuming a plant-forward whole foods diet that prioritizes nutrients and the quality of the diet. A little bit more specifically, it's important to limit the amount of red and processed meats in the diet, really limit the amount of sugar sweetened beverages, ideally to cut that out of the diet entirely, and to consume an appropriate amount of dietary fiber in the range of 20 to 30 grams per day. Those are more specific things that have been associated with breast cancer outcomes.  Dr. Hope Rugo: This is such helpful, practical information for clinicians and for patients. Thank you.  But let's move on to another area, surveillance testing for distant recurrence, an area of great interest, in fact highlighted in a special session at ASCO 2024. In clinic, we've seen that many cancer survivors expressed surprise at the less intensive approach to surveillance testing for recurrence, with the whole idea that if you detected it earlier, the outcome would be better. But it does raise an important question. What is the optimal strategy for monitoring for recurrence? And importantly, can early detection through surveillance testing impact outcome?   Dr. Elliot, your research has focused on ctDNA surveillance and the evolving role of minimal residual disease, or MRD. Can you comment on the current surveillance guidelines for distant recurrence, and then, how we really define true MRD?  Dr. Mitchell Elliott: Those are excellent questions, and I think leaving that Education Session at ASCO left us with even more questions than answers with the current role of MRD in this setting. I think a lot of this comes from wanting to help patients and trying to identify the patients at highest risk of cancer recurrence, with the goal of intervening with effective targeted therapy to prevent metastatic relapse.  Current international guidelines in the United States done by ASCO and the NCCN, as well as ESMO guidelines in Europe and even our local Canadian guidelines, do not suggest that patients undergo routine screening in asymptomatic individuals, whether it be blood work or routine radiographic imaging, as there were some studies that were done in the late 1990s and early 2000s that didn't actually show benefit and actually maybe favored a little bit of harm in these situations. So these recommendations are based on these initial studies. However, we know that in the last 10, 15 years, even 20 years, that breast cancer and the landscape of breast cancer has changed significantly with the introduction of our typical standard classification of breast cancer, the emergence of HER2 positive breast cancer, and thus triple negative breast cancer, which was not actually routine standard testing at the time of these studies, and also the most effective therapies we have to date, including immunotherapy, HER2 targeted therapy and the advent of antibody drug conjugates. We're at prime time right now to potentially revisit this question, but the question is, do we have the right technology to do so? And this is where the circulating tumor DNA has really emerged as a potential option, given its minimally invasive opportunity with a standard blood test to actually identify tumor specific DNA that is highly predictive of distant metastatic recurrence or patient recurrence in general.   The evolving role – we still have a lot of questions in this setting. There have been a lot of retrospective analyses of cohort studies and clinical trials that have shown that modern fit for purpose MRD based tests actually have a high positive predictive value at identifying patients with imminent risk of breast cancer recurrence. The most important thing in this setting is that there are different fit for purpose tests. The initial ctDNA assays were actually genotyping based assays, which look for the presence of mutations in the blood. But we know that the sensitivity of these assays is quite challenging at the level of ctDNA required to actually diagnose patients with very small amounts of residual disease. So the fit for purpose MRD assays are now emerging on the market. And we have several that are in clinical development, several that are in research development, but the high specificity in the setting is very important, which we're seeing some evolving and emerging technologies in this setting. We really don't have the data about if these interventions, so if we were to effectively deploy these MRD based ctDNA assays prospectively in patients, if they will actually improve patient outcomes, and how do we correct and address lead time bias, which might potentially affect study results?  Also, the important thing to think about in this setting is if we are able to find something, we also should have an effective therapy to actually intervene for patients, because the outcome in these trials will actually be dependent not only on identifying early breast cancer occurrence, but also delivering the best targeted intervention for that individual patient, which currently we don't understand fully.   Another really interesting thing is there was a trial, the ZEST trial, as many of our listeners may know, that was randomizing patients with patients with ctDNA detected in the adjuvant setting were randomized through either intervention or standard follow up. And going forward, is it actually an opportunity, or is it possible to actually randomize patients knowing that they have a near 100% likelihood of breast cancer recurrence to observation? So these are several ongoing questions that we have to address as we move forward to deploying this technology in the clinical space.  Dr. Hope Rugo: Really fascinating, and thanks for sharing that. I think really broad and helpful information on these ctDNA [assays] and also our surveillance guidelines, which I think really suggests that you only do surveillance for cause, other than looking for local recurrence and new cancers with breast imaging. So it is really an interesting time where we're seeing evolving technologies and evolving understanding of how we can best do this kind of testing when there are so many different assays out there. I think it's going to take a little while. And also understanding, as you pointed out, trying to target treatments when patients have emerging ctDNA to mutations. And we just have no idea yet if we're going to ultimately change outcomes. This is really helpful, and I think we'll give people a good understanding of where to think about this right now, what to look for in the future.  Now, of course, it's a nice segue into the idea of breast imaging for early breast cancer survivors because that's where we do have data. Dr. Lam, let's talk about how we optimize breast imaging in early-stage breast cancer survivors, because there's such a wide variation in breast cancer imaging survival protocols between different centers and different countries. And of course, here our group is representing two countries and really a broad geographic area. So some of the variations are when to do imaging in terms of frequency, when to start imaging and what kind of examination to do, screening versus diagnostic, MRI versus mammogram. And of course, there are some emerging imaging techniques as well. Could you tell us a little bit about the variation in imaging surveillance protocols in survivors, and the challenges and what you recommend?  Dr. Diana Lam: First off, I want to say that surveillance mammography saves lives and annual intervals are uniformly recommended among both national and international guidelines. However, we know that in practice there are variations in imaging surveillance protocols, with approximately 40% of sites performing imaging at more frequent or six-month intervals for at least one to two years. In addition, there's variation in what type of mammogram someone gets in terms of the indication. They might be getting initial diagnostic mammograms for a short period of time or screening mammograms. However, overall, there is limited evidence in improved outcomes in women getting a diagnostic versus a screening exam for asymptomatic surveillance. In addition, there is limited evidence in increased frequency of surveillance, for example, every six months versus one year.  The real difference between a screen and a diagnostic mammogram, if someone is asymptomatic in the surveillance population, primarily has to do with workflow. For screening examinations, the imaging is generally viewed after a patient leaves the facility, and it might actually take days, maybe even weeks, for the results to be delivered to the patient. In addition, if more imaging is needed, the patient will need to return back to the facility, which does diagnostic imaging work for us to work up this finding. And this practice approach causes diagnostic delays in care. It also disproportionately affects Black and Hispanic women. For diagnostic mammography surveillance, there's generally real time interpretation with immediate results. However, there are both access and scheduling limitations, as not all facilities actually perform these types of examinations. There may also be out of pocket costs which are increased due to the diagnostic indication of this exam.  So  what we found, which is an approach that can aid in minimizing patient costs and decreasing these health disparities, is to provide immediate interpretations of these screening mammography surveillance exams, or so-called online screens where diagnostic workup and potential biopsy can be performed on the same day. Dr. Hope Rugo: This is all very interesting, but what do we tell our patients? How do we, as oncologists, decide on how frequently to get mammograms? Should we be getting diagnostic or screening? And do we sequence MRI with mammograms for everybody or just for certain patients? And then some patients will say, “Well, my doctor does an ultrasound to mammogram.” We don't do that for screening. When do you recommend that? Dr. Diana Lam: We do know that compared to people without a personal history of breast cancer, surveillance mammography is actually less sensitive. It's only about 70% versus 87% or so percent sensitive with over four times more interval cancers or cancers diagnosed after a negative surveillance mammogram compared to the general screening population without a personal history of breast cancer. In addition, about 35% of invasive second breast cancers are actually interval cancers or those not detected by surveillance mammography. However, there is currently no guideline consensus on supplemental breast imaging or additional imaging beyond surveillance mammography. Contrast-enhanced breast MRI is most often recommended, particularly for patients who are already at high risk for breast cancer, such as those with genetic mutations, or patients who have had primary breast cancer diagnosed at a younger age to less than 50 years old, or those patients who have dense breast tissue on mammography.  There is a question about whole breast ultrasound and this is generally not specified or recommended unless the patient is unable to undergo breast MRI. This is primarily due to the number of false positive examinations or findings that are seen that do not amount to breast cancer. We do have the opportunity here to tailor surveillance imaging by selecting people who are at high risk for interval second breast cancers in order to decrease harms and improve patient outcomes. We know that there are a number of factors such as primary breast cancer subtype which affects second breast cancer risk. We know that women who have ER negative and/or hormonal negative breast cancers have significantly higher recurrence rates within the five years of treatment with no significant difference after that 5 years. We also know that there are certain factors such as imaging factors where patients are more likely to develop an interval second cancer with mammography surveillance only. And these are factors such as if their primary breast cancer was hormone negative, if they had an interval presentation to start, or if they had breast conservation without radiation therapy. So, in terms of the future of local breast imaging surveillance, this can be improved with upfront risk prediction and stratification based on the patient, primary breast cancer and treatment factors, as well as looking at imaging test performance to optimally guide the modality and frequency of surveillance imaging.  Dr. Hope Rugo: Really interesting.   Well, thank you all three of you for sharing your valuable insights. This has been so interesting and a great addition to the ASCO Daily News Podcast. I would encourage everyone to actually read the article as well because there's some really great tables and interesting information there that of course we don't have time to cover, but thank you, all three of you.  Dr. Diana Lam: Thank you. Dr. Mitchell Elliott: Thank you for having us. Dr. Hope Rugo: And thank you to our listeners for joining us today. You'll find a link to the article that you can read and look at and cut out the tables discussed today in the transcript of this episode. I encourage all of our listeners also to check out the 2024 ASCO Educational Book where there is an incredible wealth of useful information. Finally, if you value the insights that you've heard today and here on ASCO Daily News Podcast, please take a moment to rate, review and subscribe wherever you get your podcasts. Thanks again.   Disclaimer: The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience and conclusions. Guest statements on the podcast do not express the opinion of ASCO. The mention of any product, service, organization, activity or therapy should not be construed as an ASCO endorsement.   Follow today's speakers:   Dr. Hope Rugo   @hoperugo   @MitchElliott18 Dr. Sherry Shen @SherryShenMD    Follow ASCO on social media:       @ASCO on Twitter     ASCO on Facebook     ASCO on LinkedIn        Disclosures:      Dr. Hope Rugo:    Honoraria: Mylan/Viatris, Chugai Pharma Consulting or Advisory Role: Napo Pharmaceuticals, Puma Biotechnology, Sanofi Research Funding (Inst.): OBI Pharma, Pfizer, Novartis, Lilly, Merck, Daiichi Sankyo, AstraZeneca, Gilead Sciences, Hoffmann-LaRoche AG/Genentech, Inc., Stemline Therapeutics, Ambryx   Dr. Diana Lam: No relationships to disclose   Dr. Sherry Shen: Honoraria: MJH Life Sciences Research Funding (Inst.): Merck, Sermonix Pharmaceuticals   Dr. Mitchell Elliott:  No relationships to disclose